Contrast enhanced MR examinations across neurological, body, vascular and musculoskeletal work are what this device supports, delivering a programmed contrast volume followed by a saline flush so that the full dose reaches the circulation rather than remaining in the line. All decisions about whether contrast is indicated, which agent is used, at what dose and at what rate remain entirely with the clinical team, and Medigear.uk supplies configuration and condition detail rather than clinical or pharmacological guidance.
Consistency of delivery is the practical argument for a power injector over hand injection, particularly where timing matters to the acquisition. Dynamic and angiographic sequences depend on the bolus arriving in a predictable way, and a programmed injection is more repeatable between operators and between patients than a manual one.
The saline flush function has a straightforward economic dimension alongside the clinical one, since contrast left in the tubing is contrast paid for and not administered. Over a working year that is a measurable figure, and it is worth setting against the cost of the disposables when the total cost of running the device is calculated.
Departments considering this platform should treat it as a consumables commitment with a machine attached rather than as a capital purchase. The sensible comparison is not this unit against a newer injector on specification, but the cost per case of its disposables and the likely remaining supply window against the same figures for a currently supported platform. Medigear.uk supplies the inputs for that calculation so it can be made properly rather than approximated.



